Amsterdam-based gene therapy company uniQure NV appointed Robert Gut and David Meek to the board.
Gut is currently the chief medical officer for Versartis Inc. Meek has been the CEO of Ipsen SA since 2016.
UniQure appoints 2 board members
JMP Securities is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection
M&A rebound sparks optimism for near-term deal activity
Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection
Banking Essentials Newsletter - February Edition
UniQure appoints 2 board members
- Author Armughan Khawaja
- Theme Healthcare & Pharmaceuticals
- Author
- Armughan Khawaja
- Theme
- Healthcare & Pharmaceuticals